Refractory celiac disease

References

• Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009;373:1480–1493.
   PubMed Web of Science ®Google Scholar
• Murray JA, Watson T, Clearman B, et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2004;79:669–673.
   PubMed Web of Science ®Google Scholar
• Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol. 2005;19:413–424.
   PubMed Web of Science ®Google Scholar
• Abdulkarim AS, Burgart LJ, See J, et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97:2016–2021.
   PubMed Web of Science ®Google Scholar
• Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol. 2003;98:1079–1087.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut. 2010;59:547–557.
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56:1373–1378.
   PubMed Web of Science ®Google Scholar
• Daum S, Ipczynski R, Schumann M, et al. High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol. 2009;21:66–70.
   PubMed Web of Science ®Google Scholar
• Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136:81–90.
   PubMed Web of Science ®Google Scholar
• Maurino E, Niveloni S, Chernavsky AC, et al. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol Latinoam. 2006;36:10–22.
   PubMedGoogle Scholar
• Rubio-Tapia A, Kelly DG, Lahr BD, et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology. 2009;136:99–107. quiz 352–353.
   PubMed Web of Science ®Google Scholar
• Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 1998;114:471–481.
   PubMed Web of Science ®Google Scholar
• Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128:S87–91.
   PubMedGoogle Scholar
• O’Mahony S, Howdle PD, Losowsky MS. Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther. 1996;10:671–680.
   PubMed Web of Science ®Google Scholar
• Losurdo G, Piscitelli D, Giangaspero A, et al. Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up. World J Gastroenterol. 2015;21:7545–7552.
   PubMed Web of Science ®Google Scholar
• Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol. 2008;103:190–195.
   PubMed Web of Science ®Google Scholar
• Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther. 2006;24:47–54.
   PubMed Web of Science ®Google Scholar
• O’Leary C, Wieneke P, Healy M, et al. Celiac disease and the transition from childhood to adulthood: a 28-year follow-up. Am J Gastroenterol. 2004;99:2437–2441.
   PubMed Web of Science ®Google Scholar
• Karajeh MA, Hurlstone DP, Patel TM, et al. Chefs’ knowledge of coeliac disease (compared to the public): a questionnaire survey from the United Kingdom. Clin Nutr. 2005;24:206–210.
   PubMed Web of Science ®Google Scholar
• Bardella MT, Molteni N, Prampolini L, et al. Need for follow up in coeliac disease. Arch Dis Child. 1994;70:211–213.
   PubMed Web of Science ®Google Scholar
• Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445–450.
   PubMed Web of Science ®Google Scholar
• Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology. 2005;128:S135–141.
   PubMed Web of Science ®Google Scholar
• Mooney PD, Evans KE, Singh S, et al. Treatment failure in coeliac disease: a practical guide to investigation and treatment of non-responsive and refractory coeliac disease. J Gastrointestin Liver Dis. 2012;21:197–203.
   PubMed Web of Science ®Google Scholar
• Giorgio F, Principi M, Losurdo G, et al. Seronegative celiac disease and immunoglobulin deficiency: where to look in the submerged iceberg? Nutrients. 2015;7:7486–7504.
   PubMed Web of Science ®Google Scholar
• Mooney PD, Evans KE, Sanders DS. Letter: coeliac disease and small intestinal bacterial overgrowth–is dysmotility the missing link? Aliment Pharmacol Ther. 2014;39:902–903.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J. 2015;14:92.
   PubMed Web of Science ®Google Scholar
• Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:359–365 e1.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87:732–738.
   PubMed Web of Science ®Google Scholar
• Nath SK. Tropical sprue. Curr Gastroenterol Rep. 2005;7:343–349.
   PubMedGoogle Scholar
• Leeds JS, Horoldt BS, Sidhu R, et al. Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls. Scand J Gastroenterol. 2007;42:1214–1220.
   PubMed Web of Science ®Google Scholar
• Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126–131.
   PubMed Web of Science ®Google Scholar
• O’Leary C, Wieneke P, Buckley S, et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol. 2002;97:1463–1467.
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839–843.
   PubMed Web of Science ®Google Scholar
• Corazza GR, Biagi F, Volta U, et al. Autoimmune enteropathy and villous atrophy in adults. Lancet. 1997;350:106–109.
   PubMed Web of Science ®Google Scholar
• Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203–208.
   PubMed Web of Science ®Google Scholar
• Olaussen RW, Lovik A, Tollefsen S, et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol. 2005;3:875–885.
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Goerres MS, Meijer JW, et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4:315–319.
   PubMed Web of Science ®Google Scholar
• de Mascarel A, Belleannee G, Stanislas S, et al. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol. 2008;32:744–751.
   PubMed Web of Science ®Google Scholar
• van Wanrooij RL, Muller DM, Neefjes-Borst EA, et al. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol. 2014;34:828–835.
   PubMed Web of Science ®Google Scholar
• Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig Dis. 2007;25:230–236.
   PubMed Web of Science ®Google Scholar
• Meijer JW, Mulder CJ, Goerres MG, et al. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;241:78–84.
   PubMedGoogle Scholar
• Biagi F, Schiepatti A, Malamut G, et al. PROgnosticating COeliac patieNts SUrvivaL: the PROCONSUL score. PLoS One. 2014;9:e84163.
   PubMed Web of Science ®Google Scholar
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood. 1997;89:3909–3918. PMID: 9166827.
   PubMed Web of Science ®Google Scholar
• Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology. 2007;132:1902–1911.
   PubMed Web of Science ®Google Scholar
• Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141:1361–1371.
   PubMed Web of Science ®Google Scholar
• Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol. 2000;18:795–803.
   PubMed Web of Science ®Google Scholar
• Heine GD, Al-Toma A, Mulder CJ, et al. Milestone in gastrointestinal endoscopy: double-balloon enteroscopy of the small bowel. Scand J Gastroenterol Suppl. 2006;243:32–38.
   PubMedGoogle Scholar
• Hoffmann M, Vogelsang H, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut. 2003;52:347–351.
   PubMed Web of Science ®Google Scholar
• Joyce AM, Burns DL, Marcello PW, et al. Capsule endoscopy findings in celiac disease associated enteropathy-type intestinal T-cell lymphoma. Endoscopy. 2005;37:594–596.
   PubMed Web of Science ®Google Scholar
• Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol. 2003;21:2740–2746.
   PubMed Web of Science ®Google Scholar
• Egan LJ, Walsh SV, Stevens FM, et al. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 1995;21:123–129.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Murray JA. Celiac disease in the elderly. Gastroenterol Clin North Am. 2009;38:433–446.
   PubMed Web of Science ®Google Scholar
• Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004;2:731–743.
   PubMed Web of Science ®Google Scholar
• Cellier C, Cerf-Bensussan N. Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside. Clin Gastroenterol Hepatol. 2006;4:1320–1321.
   PubMed Web of Science ®Google Scholar
• Wahab PJ, Crusius JB, Meijer JW, et al. Cyclosporin in the treatment of adults with refractory coeliac disease–an open pilot study. Aliment Pharmacol Ther. 2000;14:767–774.
   PubMed Web of Science ®Google Scholar
• Mulder CJ, Wahab PJ, Meijer JW, et al. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol. 2001;13:1183–1188.
   PubMed Web of Science ®Google Scholar
• Vivas S, Ruiz de Morales JM, Ramos F, et al. Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. N Engl J Med. 2006;354:2514–2515.
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Goerres MS, Meijer JW, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol. 2006;4:1322–1327. quiz 00.
   PubMed Web of Science ®Google Scholar
• Schmidt C, Kasim E, Schlake W, et al. TNF-alpha antibody treatment in refractory collagenous sprue: report of a case and review of the literature. Z Gastroenterol. 2009;47:575–578.
   PubMed Web of Science ®Google Scholar
• Jamma S, Leffler DA, Dennis M, et al. Small intestinal release mesalamine for the treatment of refractory celiac disease type I. J Clin Gastroenterol. 2011;45:30–33.
   PubMed Web of Science ®Google Scholar
• Al-toma A, Visser OJ, Van Roessel HM, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood. 2007;109:2243–2249.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Fassas A, Passweg J, et al. Autologous haematopoietic stem cell transplants for autoimmune disease–feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant. 1999;24:729–734.
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Verbeek WH, Visser OJ, et al. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis. 2007;39:634–641.
   PubMedGoogle Scholar
• Hadithi M, Al-toma A, Oudejans J, et al. The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol. 2007;102:987–996.
   PubMed Web of Science ®Google Scholar
• Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.
   PubMed Web of Science ®Google Scholar
• Tsakris A, Woodford N, Pournaras S, et al. Apparent increased prevalence of high-level aminoglycoside-resistant Enterococcus durans resulting from false identification by a semiautomated software system. J Clin Microbiol. 1998;36:1419–1421.
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Ciccocioppo R, Cupelli F, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut. 2006;55:469–477.
   PubMed Web of Science ®Google Scholar
• Benahmed M, Meresse B, Arnulf B, et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007;132:994–1008.
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Perera PY, Waldmann TA, et al. Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J Clin Immunol. 2013;33:586–594.
   PubMed Web of Science ®Google Scholar